Shire Pulls US Drug Application, Blames FDA Delay
Irish pharmaceutical company Shire PLC said Wednesday that it has pulled its U.S. application for Replagal, which treats a rare and potentially life-threatening genetic disorder, because regulators would take too long...To view the full article, register now.
Already a subscriber? Click here to view full article